by admin | Jun 4, 2020 | 2020, Post-Pipeline
2A Pharma’s anti-amyloid-beta vaccine candidate, AAVLP-Amyloid-β, has in laboratory tests with transgenic mice overexpressing amyloid-beta mutant protein been shown to eliminate amyloid-beta soluble protein, clear plaque from the cortex and significantly reduce plaque...
Recent Comments